Manhattan BioSolutions, Inc. Selected to be Featured in New York Pavilion at BIO International Convention
May 22, 2023
New York City, New York May 22, 2023 (Issuewire.com) - Manhattan BioSolutions, Inc. ("Manhattan Bio"), an emerging biotechnology company developing new classes of precision biologics for the treatment of age-related diseases, announced that it has been chosen to participate in the New York State pavilion at the BIO International Convention, the world's largest and most influential event for the pharmaceutical and biotechnology industry being held June 5-8 in Boston. The participation of Manhattan Bio at the New York pavilion is sponsored by the New York State Center for Biotechnology (CFB) at Stony Brook University.
"We are honored to have been selected as one of the participants in the New York State pavilion at this year's BIO International Convention," said Manhattan Bio Chief Executive Officer Borys Shor, Ph.D. "We are grateful for the support of the CFB and look forward to showcasing our latest work, and connecting with leaders in the biotech industry."
The CFB has expressed its pleasure in supporting Manhattan Bio and two other biotech companies to be part of this year's New York State pavilion at BIO. "The BIO event offers a tremendous platform for companies around the world to explore partnerships with universities, businesses, and the investment community," said Diane Fabel, Ph.D., Director of Operations for the CFB. "We are thrilled to support client companies to participate in the event to spotlight the innovative science and business happening in New York State."
About Manhattan BioSolutions
Manhattan BioSolutions, Inc is a privately held biotechnology company focused on the development of biologic immunotherapies that target host defense pathways for the treatment of age-related diseases. The company has established partnerships with the National Institutes of Health (NIH), Stony Brook University, Binghamton University, The University at Buffalo, INSERM, and EVQLV and has been awarded grants by the National Institutes of Health (NIH), the National Science Foundation (NSF), the New Jersey Commission on Science, Innovation, and Technology (CSIT) and the University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UBCAT).
About the Center for Biotechnology
Established in 1983, the Center for Biotechnology (CFB) at Stony Brook University is an Empire State Development Division of Science, Technology, and Innovation (NYSTAR) Center for Advanced Technology. The CFB serves as an important catalyst in the development of new biomedical technology and emerging companies in New York State. Through groundbreaking initiatives, the CFB supports technology commercialization and company formation by bridging the gap between discovery and commercial success and training the next generation of biomedical leaders. The CFB also supports New York's biotechnology industry by providing access to scientific and business expertise and creating strategic infrastructure that promotes the growth of the life sciences industry in the state. The CFB has contributed to the development of more than a dozen FDA-approved products including ReoPro®, Xiaflex®, Oracea®, Cavistat®, V3D®-Colon Virtual Colonoscopy and Exogen® Bone Healing System, among others, as well as supporting the formation or development of dozens of emerging bioscience companies.
Contact for investor inquiries
Jordana Lovett, PhD
Director of Investor Relations
(917) 740-2111
[email protected]
Source :Manhattan BioSolutions, Inc.
This article was originally published by IssueWire. Read the original article here.
More News
The Bottom Line
How does the antiques industry work and is it accurately portrayed on television shows?
Pension tops £16,000 a year after 4.7% increase
The full pension rises by £734 a year, or about £14 a week, the Government of Jersey says.
AI boom could trigger market shocks, Bank of England boss warns
Andrew Bailey says the central bank is watching the waves of cash being invested in artificial intelligence "very carefully".
Oil Is Flowing From the Persian Gulf, but Prices Remain High. Why?
Crude oil costs close to $100 a barrel because traders are worried hostilities could soon restart and the world is burning through its emergency stockpiles.
When Data Centers Cluster Together, How Dirty Are They? One County Wants Answers.
An unusual study aims to estimate the pollution and health costs from a cluster of proposed data centers, instead of considering each one separately.
Help! Air Canada Got Me to Europe, Then Stranded Me There.
The airline helpfully rebooked a delayed traveler from Toronto, but failed to mention it had also canceled her return trip. She spent $800 to get home.
'We're still cold paying £300 a month energy bills'
A pensioner says trying to keep warm this winter will be "horrific" amid rising energy costs.
Energy bills are rising by £60 a year - here's how you can bring that down
Household energy bills have risen again but there are ways to keep a lid on your expenditure.
Employers should teach primary-age children about work, says Milburn
The author of a major report into youth activity in the UK says children as young as four should be learning about careers.
Africa's richest man launches Kenya oil refinery despite land protests
The Kenya refinery is part of Dangote's ambitious bid to expand and help industralise Africa by 2030.
Fuel prices leave people asking 'what can we do?'
Record fuel prices across the country have left people in the South looking for ways to cope.
'We're still cold paying £300 a month energy bills'
Redditch residents say they are worried they will not be able to afford heating.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.